Most people are familiar with A, B, AB and O blood types, but there are hundreds of additional blood group “antigens” on red blood cells – substances that can trigger the body’s immune response – that differ from person to person. Each year, up to 16 deaths reported to the Federal Drug Administration are attributed to mismatches in red blood cell antigens that are not related to differences in A, B and O blood groups. Currently, no method is available that can determine all blood antigens. But as whole genome sequencing becomes routine for patients, it may be possible to modernize therapy by identifying both rare donors and at-risk recipients before blood transfusions.
In a new study, investigators from Brigham and Women’s Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project – the first randomized trial of whole genome sequencing in healthy adults – to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals’ blood types with more than 99 percent accuracy. The team’s results are reported in The Lancet Haematology.
“Blood transfusion complications are common in patients needing chronic transfusion, but with current technology it is not cost effective to do blood typing for all antigens,” said first author William Lane, MD, PhD, director of Clinical Laboratory Informatics and assistant director of the Tissue Typing Laboratory in the BWH Department of Pathology. “But the algorithm we have developed can be applied to type everyone for all relevant blood groups at a low cost once sequencing is obtained.”
Blood transfusions are one of the most common procedures in medicine with more than 11 million units of blood transfused in the U.S. each year. Complications from blood transfusions can be life-threatening. When the body encounters foreign antigens on the donor cells, it can stimulate production of antibodies that can destroy the transfused donor cells. From birth, people have antibodies unique to their ABO blood type, but other antibodies against specific blood antigens can be stimulated during pregnancy from exposure to fetal cells or exposure to donor cells when receiving multiple blood transfusions.
“This approach has the potential to be one of the first routine clinical uses of genomics for medical care for patients needing blood transfusion,” said co-first author Connie M. Westhoff, PhD, at the New York Blood Center. “It could prevent serious or even fatal complications because once patients are sensitized they have a life-long risk of hemolytic transfusion reactions if blood transfusion is needed in an emergency.”
Today, most testing for blood donors and patients include only ABO and Rh matching, but more than 300 red blood cell antigens and 33 platelet antigens are known. To create a way to cost-effectively type many people for these antigens, Lane teamed up with scientists directing the MedSeq Project and experts in blood group genetics at the New York Blood Center to build a database and develop a computer software algorithm, known as bloodTyper, that could rapidly and accurately predict an individual’s blood group antigen profile from genomic sequences. Lane, Westhoff and colleagues validated the software by comparing it to traditional, and more labor-intensive, methods. bloodTyper was more than 99 percent accurate when typing from the MedSeq Project participants’ genomes. Lane notes that this work would not have been possible without access to samples from the MedSeq Project, and close collaboration with MedSeq’s principal investigator, Robert Green, MD, MPH, and co-investigator, Heidi Rehm, PhD.
“This report demonstrates a previously unanticipated use case and benefit that will accrue as whole genome sequencing become a routine part of medical care,” said Green, one of the senior authors on the study, director of the Genomes2People Research Program at BWH and professor of medicine at Harvard Medical School. “Genome sequencing can now identify potential transfusion recipients who need rare blood types and the individuals who can safely provide them.”
The Latest on: Whole genome sequencing
via Google News
The Latest on: Whole genome sequencing
- Philippine Genome Center ready to help in detecting nCoV in PHLon February 1, 2020 at 7:25 am
In a news item posted on the PGC website, the center said that they would use whole genome sequencing and "Next Generation DNA/RNA Sequencing" (NGS) equipment in verifying the presence of nCOV in ...
- Genomic surveillance detects Salmonella enterica serovar Paratyphi A harbouring blaCTX-M-15 from a traveller returning from Bangladesh.on January 31, 2020 at 5:40 am
Whole genome sequencing (WGS) has been used routinely by Public Health England (PHE) for identification, surveillance and monitoring of resistance determinants in referred Salmonella isolates since ...
- DNA Testing And Families Of Wealthon January 31, 2020 at 5:15 am
Understanding DNA can unlock a whole new world for families but also holds some risks and ethical questions that become particularly relevant for families of wealth.
- Whole genome sequence-based haplotypes reveal a single origin of the 1393 bp HBB deletionon January 30, 2020 at 6:22 pm
We have identified three individuals with haemoglobin Sβ 0-thalassaemia in which the β 0-thalassaemia mutation is caused by a large deletion. Objective To use whole genome sequence data to determine ...
- Genome mapping tracks food-born illnesson January 30, 2020 at 10:44 am
TORONTO — Whole-genome sequencing has changed the ability of public health officials to identify various strains of pathogens that sicken Canadians every year. “With genetic testing we can ...
- Genotype phasing in pedigrees using whole-genome sequence dataon January 29, 2020 at 5:40 am
We present a novel method for phasing genotypes from whole-genome sequence data in pedigrees, called PULSAR (Phasing Using Lineage Specific Alleles/Rare variants). The method is based on the property ...
- Helix and Renown Health publish largest-ever genome-wide rare variant analysis on thousands of clinical phenotypes and over 70,000 exomeson January 29, 2020 at 5:00 am
/PRNewswire/ -- Researchers from Helix and Renown Health recently published the first-ever study to interrogate rare variants across two of the ...
- Genome Reference Database Published on Healthy Elderly Individualson January 24, 2020 at 5:31 am
Here we describe the first release of the MGRB, comprising whole genome sequence and phenotype of 2,570 elderly Australians depleted for cancer, cardiovascular disease, and dementia. We analyse the ...
- Exome sequencing in newborns with congenital deafness as a model for genomic newborn screening: the Baby Beyond Hearing projecton January 23, 2020 at 5:21 pm
Genet Med. 2015;17:501–504. Goldenberg AJ, Dodson DS, Davis MM, Tarini BA. Parents’ interest in whole-genome sequencing of newborns. Genet Med. 2014;16:78–84. Bodian DL, Klein E, Iyer RK, et al.
via Bing News